Liquid Biopsy Enabling Precision Oncology Clinical Trials
- Defining ctDNA guided clinical trial designs and assay performance requirements for each
- Showcasing ctDNA as a key secondary endpoint of th e TRIDENT-1 clinical trial, a case study discussion
- Partnering on the development of a WGS MRD distributed kit